InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
T+90 hit rate
50%
T+90 mean return
+14.6%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Ades Alan A., Director. Director active across 1 company, notably Organogenesis Holdings Inc.. In total, 8 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €104.6m. Activity tracked since 6 May 2021. The latest transaction was disclosed on 9 January 2025 (Don). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
6,401,945 shares0Class A Common StockSEC:0001062993-25-000728:0
6,401,945 shares0Class A Common StockSEC:0001062993-25-000727:0
1,710,552 shares0Class A Common StockSEC:0001062993-25-000287:0
1,710,552 shares0Class A Common StockSEC:0001062993-25-000286:0
3,887,500 shares@ US$16.407.95% mcap50.0% of flowClass A Common StockSEC:0001661181-21-000049:0
3,887,500 shares@ US$16.4050.0% of flowClass A Common StockSEC:0001661181-21-000049
23,855,148 shares0Class A Common StockSEC:0001661181-21-000039
23,855,148 shares0Class A Common StockSEC:0001661181-21-000039:0
8 of 8 declarations
About Ades Alan A.
Alan A. Ades is a Director at Organogenesis Holdings Inc. As a board member, he contributes to the governance and strategic direction of the company. Alan brings his expertise to help guide decisions that support the mission and objectives of Organogenesis.
